Global EV and PHEV Sales Market Report 2018

In this report, the global EV and PHEV market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of EV and PHEV for these regions, from 2013 to 2025 (forecast), covering

United States

China

Europe

Japan

Southeast Asia

India

Global EV and PHEV market competition by top manufacturers/players, with EV and PHEV sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

Volvo

Volkswagen

Toyota

Tesla

BMW

Porsche

Nissan

Mitsubishi

Kia

Hyundai

Honda

Ford

Fiat

Chevrolet

Audi

BYD

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

EV

PHEV

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Commercial Vehicle

Passenger Vehicle

If you have any special requirements, please let us know and we will offer you the report as you want.

 

 

Intracranial pressure monitors market is poised to reach US$1.85 bn by 2025

Traumatic brain injuries and strokes remain one of the leading causes of death and disability across the globe. The upswing in the cases of brain injuries in adults as well as children has proved to be a shot in the arm for the global intracranial pressure monitors market. The Centers for Disease Control and Prevention states that every day nearly 140 people in the U.S. die from injuries that are associated with traumatic brain injuries.  According to a report by Crystal Market Reports, the opportunity in the global intracranial pressure monitors market was pegged at $1 Billion in 2015 and is poised to reach US$1.85 bn by 2025, rising at a CAGR of 6.30% between 2015 and 2025. A CMR analyst states that the sweeping shift towards non-invasive pressure monitors from invasive ones is likely to have a positive and enduring impact on the dynamics of the market.

Global Unfractionated Heparin Market - CMR

With the presence of a copious number of large global players, the global unfractionated heparin market is marked by a highly consolidated vendor landscape. Large players are focused on mergers and strategic collaborations with small players to establish a foothold in regional markets. Savvy players are investing in emerging economies of Asia Pacific and Latin America that are swarming with opportunities owing to the modernization of healthcare facilities. The varied use of unfractionated heparin for medical care is the key driving factor of the unfractionated heparin market. Unfractionated heparin finds primary use as an anticoagulant for surgeries and for dialysis. In addition, unfractionated heparin is used for treating blood clotting disorders such as pulmonary embolism and deep vein thrombosis. Blood clotting disorders such as deep vein thrombosis have been on the rise over the past few years. Cohort studies suggest that deep vein thrombosis affects almost 900,000 individuals in the U.S. each year.

The global market for enteric disease testing is foreseen to touch approximately 1.20 Billion in 2025

The enteric disease testing market has a lot to offer for the global vendors, especially in the developing regions of the world. Meridian Bioscience, DiaSorin, Biomerica, Alere, and Cepheid are some of the influential vendors operating in the international enteric disease testing market. Over 85% of enteric infections are accounted by emerging nations. As per Centers for Disease Control and Prevention (CDC), an estimated 2.0 Million children die each year, primarily in developing countries, due to diarrheal and enteric diseases. The global market for enteric disease testing is foreseen to touch approximately 1.20 Billion in 2025, according to a market intelligence report by Crystal Market Reports.